Results 21 to 30 of about 1,974,567 (160)

3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE). [PDF]

, 2023
BACKGROUND The Amulet (Abbott) left atrial appendage occluder investigational device exemption trial is the largest randomized trial evaluating the safety and effectiveness of the Amulet left atrial appendage occluder compared with the Watchman 2.5 ...
Windecker, Stephan, Nielsen-Kudsk, Jens Erik, Lakkireddy, Dhanunjaya, Anderson, Jordan A, Nair, Devi, Worthley, Stephen, Schmidt, Boris, Gambhir, Alok, Horton, Rodney, Swarup, Vijendra, Alkhouli, Mohamad, Ellis, Christopher R, Gupta, Nigel, Gage, Ryan, Hermiller, James, Thaler, David   +15 more
core   +2 more sources

“A heart within the heart”: A rare case of a large left atrial appendage occluder device–related thrombus [PDF]

HeartRhythm Case Reports
Kalaba F, Saba S, Kassar A, Machado C, Shah D.   +4 more
exaly   +2 more sources

Retrieval of a Disconnected Left Atrial Appendage Occluder with Endoscopic Grasping Forceps [PDF]

Chinese Medical Journal, 2018
Lu Yu, Ru-Hong Jiang, Yi-Qi Ruan, Chen-Yang Jiang   +3 more
doaj   +2 more sources

1% Aspiration, 99% Perspiration

JACC: Case Reports, 2020
A 71-year-old man with chronic atrial fibrillation underwent insertion of a left atrial appendage occlusion device. Before release, a large thrombus was noted within the left atrium, attached to the left atrial appendage occluder delivery system.
Pankaj Jain, MBBS, Neil Jacobs, MBBS, David W.M. Muller, MBBS, MD, Brendan Gunalingam, MBBS   +3 more
doaj   +1 more source

Left atrial appendage (LAA) electrical isolation by Maze‐like catheter substrate modification in presence of LAA‐occluder device: A case report

Clinical Case Reports, 2020
Maze‐like linear substrate modification in atrial fibrillation patients nonresponders to pulmonary vein isolation represents a feasible technique to gain left atrial appendage electrical isolation even in the presence of a Watchman occluder device.
Simone Zanchi, Lorenzo Bianchini, Stefano Bordignon, Fabrizio Bologna, Shota Tohoku, Shaojie Chen, Julian K. R. Chun, Boris Schmidt   +7 more
doaj   +1 more source

History of Percutaneous Left Atrial Appendage Occlusion with AMPLATZER Devices. [PDF]

, 2018
AMPLATZER devices preceded WATCHMAN occluder in 2002 for catheter-based left atrial appendage occlusion. The AMPLATZER technique facilitates simultaneous closure of atrial shunts using two devices through one gear.
Stegink, Wim, Apostolos Tzikas, Wim Stegink, Bernhard Meier, Tzikas, Apostolos, Meier, Bernhard   +5 more
core   +2 more sources

Cardioform Septal Occluder in the Management of Cardiac Tamponade as a Complication of LAA Closure

JACC: Case Reports, 2020
Cardiac tamponade is a life-threatening complication during left atrial appendage (LAA) closure. We report a 77-year-old woman who underwent a transseptal puncture for LAA closure with the Watchman device that was complicated by tamponade.
Nabil Braiteh, MD, Mouhamed Amr Sabouni, MD, Alon Yarkoni, MD   +2 more
doaj   +1 more source

Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study [PDF]

, 2011
Background To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks.
Steffen E Petersen, Petersen, SE, Mohrs, OK, Nina Wunderlich, Anselm Pottmeyer, Petersen Steffen E, Wunderlich, N, Pottmeyer, A, Hans-Ulrich Kauczor, Mohrs Oliver K, Pottmeyer Anselm, Kauczor, HU, Wunderlich Nina, Kauczor Hans-Ulrich, Oliver K Mohrs   +14 more
core   +1 more source

Modification of the left atrial appendage and its role in stroke risk reduction with non-valvular atrial fibrillation

International Journal of Cardiology: Heart & Vasculature, 2021
Atrial fibrillation is one of the most common cardiovascular disorders encountered by clinicians in clinical practice. Patients with atrial fibrillation are at risk of cerebrovascular and systemic embolic events, which may be attenuated by commencement ...
Hashrul N. Rashid, Jamie Layland
doaj   +1 more source

Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial). [PDF]

, 2019
The Amulet IDE Trial is an ongoing, prospective, randomized, multi-national trial, designed to evaluate the safety and effectiveness of the AMPLATZER Amulet Left Atrial Appendage Occluder for stroke prevention in comparison to the WATCHMAN Left Atrial ...
Gold, Michael R, Guo, Hongfei, Brunner, Kyle J, Windecker, Stephan, Hermiller, James B, Lakkireddy, Dhanunjaya, Søndergaard, Lars, Diener, Hans-Christoph, Schmidt, Boris, MacDonald, Lee, Mansour, Moussa, Carroll, John, Levine, Joseph, Thaler, David, Maini, Brijeshwar   +14 more
core   +2 more sources